
FDA grants ravulizumab accelerated approval in IgA nephropathy after a 43.4% proteinuria cut, signaling new IV biologic demand for drug manufacturers.
A pilot program will offer instruction on scientific and regulatory guidelines including training on GMPs and quality.
On August 14, 2017, the International Council for Harmonization (ICH) announced a training pilot program that will partner its Training Subcommittee with a group of trainers to provide instruction on ICH scientific and regulatory principles. ICH will evaluate the pilot program at the end of 2017 to determine a longer-term training strategy
The committee performed a needs assessment survey to determine which guidelines needed training. The following training will be provided:
ICH-endorsed programs will include the ICH logo.
Source:






